Home > Press > SAVE THE DATE - Harris & Harris Group Meet the Portfolio Day - March 13, 2012
2011 was a break-out year for nanotechnology, and we welcome you to come hear in person how these companies are transforming their industries. During lunch (12:20 – 1:30 PM EST), attendees will have the opportunity to speak with the CEOs of the presenting companies. |
Abstract:
SAVE THE DATE
"Meet the Portfolio" Day
Tuesday, March 13, 2012 - NASDAQ MarketSite
Four Times Square (43rd Street & Broadway), New York City
Harris & Harris Group, an early-stage, active investor in transformative nanotechnology companies,
is hosting a "Meet the Portfolio" Day to provide 10 portfolio company CEOs the opportunity to highlight their companies' commercial progress.
Two of our featured companies successfully completed IPOs in 2011.
For more information, please contact Harriet Fried of LHA at 212-838-3777 or via email at .
If you cannot join us in person, presentations will be webcast at www.hhvc.com.
####
About Harris & Harris Group
Harris & Harris Group is an early-stage, active investor in transformative nanotechnology companies. With offices in New York City and Palo Alto, Harris & Harris Group currently has more than 25 companies in its investment portfolio.
For more information, please click here
Contacts:
Harriet Fried
LHA
212-838-3777
Copyright © Harris & Harris Group
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
VC/Funding/Angel financing/Loans/Leases/Crowdfunding
Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||